Cargando…
Response to COVID-19 and diabetes: Can DPP4 inhibition play a role? – GLP-1 might play one too
Autor principal: | Morin, Nathaniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175913/ https://www.ncbi.nlm.nih.gov/pubmed/32333969 http://dx.doi.org/10.1016/j.diabres.2020.108160 |
Ejemplares similares
-
COVID-19 and diabetes: Can DPP4 inhibition play a role?
por: Iacobellis, Gianluca
Publicado: (2020) -
Letter to the editor in response to the article “COVID-19 and diabetes: Can DPP4 inhibition play a role?”
por: Kokic Males, Visnja
Publicado: (2020) -
Endogenous GLP-1 levels play an important role in determining the efficacy of DPP-IV Inhibitors in both prediabetes and type 2 diabetes
por: Chong, Shiau Chin, et al.
Publicado: (2022) -
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
por: Monda, Vincenzo M., et al.
Publicado: (2020) -
Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?
por: Cirmi, Santa, et al.
Publicado: (2016)